Predictions
Adler Real Estate AG
Start price
Target price
Perf. (%)
€7.24
11.01.22
11.01.22
€8.00
11.01.23
11.01.23
-11.46%
24.01.22
24.01.22
Low dividend yield expected
negative Cash Flow expected
Few uniques
Dependend from some customers or products
Osmotica Pharmaceuticals PLC
Start price
Target price
Perf. (%)
€1.01
11.01.22
11.01.22
€1.50
11.01.23
11.01.23
12.87%
12.01.23
12.01.23
Could be worthwhile Investment >10% per year
2G Energy AG
Start price
Target price
Perf. (%)
€98.40
10.01.22
10.01.22
€115.00
10.01.23
10.01.23
-1.42%
21.02.22
21.02.22
Top 10 in its market
Revenue growth >5% per year expected
Sustainability is very important
Significant cyclical dependencies
Innate Pharma
Start price
Target price
Perf. (%)
€4.12
10.01.22
10.01.22
-
10.01.23
10.01.23
-14.85%
01.02.22
01.02.22
Could be worthwhile Investment >10% per year
Marathon Digital Holdings
Start price
Target price
Perf. (%)
€25.00
10.01.22
10.01.22
-
10.01.23
10.01.23
-22.72%
23.01.22
23.01.22
Risky Investment
Ata Inc. ADR
Start price
Target price
Perf. (%)
€2.10
09.01.22
09.01.22
€2.50
09.01.23
09.01.23
-39.17%
10.01.23
10.01.23
Some uniques
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€3.02
09.01.22
09.01.22
-
09.01.23
09.01.23
-18.54%
23.01.22
23.01.22
Could be very worthwhile Investment >20% year
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.81
09.01.22
09.01.22
-
09.01.23
09.01.23
-12.41%
23.01.22
23.01.22
Could be very worthwhile Investment >20% year
CytoDyn Inc_INT
Start price
Target price
Perf. (%)
€0.66
09.01.22
09.01.22
€0.20
09.01.23
09.01.23
-1.09%
21.07.22
21.07.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
SNP Schneider-Neureither & Partner AG
Start price
Target price
Perf. (%)
€36.36
09.01.22
09.01.22
€27.00
09.01.23
09.01.23
-19.91%
16.03.22
16.03.22
high free float
Higher risks for its business
Very high cyclical dependencies
Little known brand
Frequentis AG
Start price
Target price
Perf. (%)
€33.70
09.01.22
09.01.22
€38.00
09.01.23
09.01.23
-22.85%
24.01.22
24.01.22
Future proof or reliable business model
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Very low/no dividend yield expected
Overstock.com
Start price
Target price
Perf. (%)
€47.35
09.01.22
09.01.22
-
09.01.23
09.01.23
-3.13%
10.02.22
10.02.22
Stable Large shareholder and/or long term investor
EBIT decline/stagnation expected
Few uniques
Sustainability is little important
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€3.71
09.01.22
09.01.22
-
09.01.23
09.01.23
-11.02%
22.01.22
22.01.22
Could be worthwhile Investment >10% per year
Gamestop Corp.
Start price
Target price
Perf. (%)
€31.23
09.01.22
09.01.22
-
09.01.23
09.01.23
-32.39%
21.01.22
21.01.22
Risky Investment
overvalued
Outdated or very high risk business model
High risks in the balance sheet
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€13.26
09.01.22
09.01.22
-
09.01.23
09.01.23
7.05%
10.01.23
10.01.23
Risky Investment
Uranium Energy Corp
Start price
Target price
Perf. (%)
€3.47
08.01.22
08.01.22
-
08.01.26
08.01.26
-1.31%
27.06.22
27.06.22
Could be worthwhile Investment >10% per year
BICO Group AB
Start price
Target price
Perf. (%)
€22.96
08.01.22
08.01.22
€44.00
08.01.23
08.01.23
-7.93%
22.01.22
22.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Magenta Therapeutics
Start price
Target price
Perf. (%)
€4.08
08.01.22
08.01.22
€6.00
08.01.23
08.01.23
-26.40%
22.01.22
22.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Liquidia Technologies Inc
Start price
Target price
Perf. (%)
€5.42
08.01.22
08.01.22
€10.00
08.01.23
08.01.23
-11.22%
22.01.22
22.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
CropEnergies AG
Start price
Target price
Perf. (%)
€12.70
08.01.22
08.01.22
-
08.01.23
08.01.23
12.91%
09.01.23
09.01.23
Higher EBIT margin than peer group
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected